Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
In December 2019, the world awoke to a new betacoronavirus strain named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Betacoronavirus consists of A, B, C and D subgroups. Both SARS-CoV and SARS-CoV-2 belong to betacoronavirus subgroup B. In the present study, we divided betacoronavirus subgroup B into the SARS1 and SARS2 classes by six key insertions and deletions (InDels) in betacoronavirus genomes, and identified a recently detected betacoronavirus strains RmYN02 as a recombinant strain across the SARS1 and SARS2 classes, which has potential to generate a new strain with similar risk as SARS-CoV and SARS-CoV-2. By analyzing genomic features of betacoronavirus, we concluded: (1) the jumping transcription and recombination of CoVs share the same molecular mechanism, which inevitably causes CoV outbreaks; (2) recombination, receptor binding abilities, junction furin cleavage sites (FCSs), first hairpins and ORF8 s are main factors contributing to extraordinary transmission, virulence and host adaptability of betacoronavirus; and (3) the strong recombination ability of CoVs integrated other main factors to generate multiple recombinant strains, two of which evolved into SARS-CoV and SARS-CoV-2, resulting in the SARS and COVID-19 pandemics. As the most important genomic features of SARS-CoV and SARS-CoV-2, an enhanced ORF8 and a novel junction FCS, respectively, are indispensable clues for future studies of their origin and evolution. The WIV1 strain without the enhanced ORF8 and the RaTG13 strain without the junction FCS “RRA R ” may contribute to, but are not the immediate ancestors of SARS-CoV and SARS-CoV-2, respectively.
Article activity feed
-
-
-
SciScore for 10.1101/2020.07.22.213926: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources SVDetect v0.8b and SVFilter [18] were used to removed abnormal aligned reads. SVDetectsuggested: (SVDetect, RRID:SCR_010812)Sequence alignment was performed using the Bowtie v0.12.7 software with paired-end alignment allowing 3 mismatches; mutation detection and other data processing were carried out using Perl scripts; the phylogenetic analysis was performed using MEGA v7.0.26; Statistics and plotting were conducted using the software R v2.15.3 the Bioconductor packages [23]. Bowt…SciScore for 10.1101/2020.07.22.213926: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources SVDetect v0.8b and SVFilter [18] were used to removed abnormal aligned reads. SVDetectsuggested: (SVDetect, RRID:SCR_010812)Sequence alignment was performed using the Bowtie v0.12.7 software with paired-end alignment allowing 3 mismatches; mutation detection and other data processing were carried out using Perl scripts; the phylogenetic analysis was performed using MEGA v7.0.26; Statistics and plotting were conducted using the software R v2.15.3 the Bioconductor packages [23]. Bowtiesuggested: (Bowtie, RRID:SCR_005476)MEGAsuggested: (Mega BLAST, RRID:SCR_011920)Bioconductorsuggested: (Bioconductor, RRID:SCR_006442)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-